|
시장보고서
상품코드
2058594
감염증 체외진단 시장 : 제품 유형별, 용도별, 병원체 유형별, 기술별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)Infectious Disease In Vitro Diagnostics Market, By Product Type, By Application, By Pathogen Type, By Technology, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
감염증 체외진단 시장 규모는 2025년에 252억 380만 달러로 평가되었으며, 2026년부터 2033년까지 CAGR 3.2%로 확대될 것으로 전망됩니다.
감염증 체외진단이란 혈액, 타액, 조직 등 인체 검체에서 세균, 바이러스, 진균 및 기타 병원체를 검출하기 위해 사용되는 실험실 기반 검사 및 분석 시스템을 의미합니다. 이러한 진단 솔루션은 의료진이 질병을 조기에 파악하고, 치료 방침을 결정하며, 감염 확산을 모니터링하고, 병원, 검사실, 진료소에서의 공중보건 관리를 지원하는 데 도움이 됩니다.
감염증 체외진단 시장은 신속한 질병 검출, 검사실의 현대화, 그리고 감염병 발생에 대한 대비에 대한 관심이 높아짐에 따라 확대되고 있습니다. 각국 정부와 의료 기관은 호흡기 감염증, 결핵, 간염, HIV 및 항생제 내성에 대한 감시 체계를 강화하기 위해 진단 인프라 구축을 추진하고 있습니다. 세계보건기구(WHO)는 국제 결핵 검사 및 약물 내성 감시 프로그램에서 분자진단의 중요성을 강조하고 있습니다. 또한, CDC는 항생제 내성 검사 네트워크 및 유전체 감시 활동에 대한 자금 지원을 적극적으로 실시하고 있습니다.
감염증 체외진단 시장 - 시장 역학
진단 검사의 수요를 뒷받침하는, 질병의 조기 발견과 공중보건 대비에 대한 관심 증가
조기 질환 발견과 공중보건 대비에 대한 관심이 높아지고 있는 것이 감염증 체외진단 시장의 성장을 뒷받침하고 있습니다. 이는 의료 시스템이 세균, 바이러스, 진균 감염증을 신속하게 규명하는 것을 여전히 최우선으로 삼고 있기 때문입니다. 각국 정부는 진단 지연을 줄이고 감염 대책을 개선하기 위해 실험실 감시 프로그램을 강화하고 분자 검사 기술에 대한 접근성을 확대하고 있습니다. 세계보건기구(WHO)는 특히 감염병 부담이 큰 지역에서 결핵 검출 및 약물 내성 선별을 위해 신속한 분자진단 도구가 필수적이라고 강조하고 있습니다. 공중보건 기관 또한 병원 및 검사 기관에 호흡기질환, 항생제 내성, 신종 병원체에 대한 검사 인프라의 현대화를 장려하고 있습니다.
업계와 관련하여, 애보트 래버러토리스는 분자진단 기술 및 병원, 진료소, 기타 분산형 의료 시설에 최적화된 현장 진단(POCT)을 활용한 신속 진단 검사 제품의 개발을 지속하고 있습니다. 또한, 애보트는 호흡기 바이러스, 간염, 성병을 포함한 감염증 검사를 위한 새로운 기능을 개발했습니다. 이러한 개발 성과는 의료진이 검사 소요 시간을 단축하고, 조기 치료 결정을 지원하며, 향후 감염병 유행에 대비하는 데 도움이 되고 있습니다.
감염증 체외진단 시장 - 시장 세분화 분석:
전 세계 감염증 체외진단 시장은 제품 유형, 용도, 병원체 유형, 기술, 최종사용자 및 지역별로 세분화되어 있습니다.
제품 유형별 시장에서는 시약이 큰 비중을 차지할 것으로 예상됩니다. 이는 병원이나 검사실에서 감염병 진단을 할 때 시약에 대한 지속적이고 반복적인 수요가 있기 때문입니다. 이 시약은 HIV, 간염, 호흡기 감염증 등의 질환에 대한 분자진단, 면역측정 및 미생물학적 검사에서 널리 사용되고 있습니다. 장비와 달리 시약은 소모품이며, 빈번한 보충이 필요하기 때문에 지속적인 시장 수요가 보장됩니다. 자동화 및 고처리량 진단 시스템의 도입 확대는 검사 속도와 효율을 향상시킴으로써 시약 소비를 더욱 촉진하고 있습니다. 또한, 질환의 조기 발견과 정기적인 검진에 대한 관심이 높아지면서 의료 현장 전반에서 시약 사용이 증가하고 있습니다.
주요 시장 참여자들은 증가하는 수요에 부응하기 위해 시약 제품 라인업을 확대하고 있습니다. 써모피셔 사이언티피크는 분자진단용 시약 공급을 지속적으로 강화하고 있는 반면, QIAGEN은 감염증 검사 워크플로우를 지원하는 다양한 시료 전처리 시약 및 어세이 키트를 제공하고 있습니다.
감염증 체외진단 시장 - 지역별 분석
의료 시스템이 질병의 조기 발견, 항생제 내성 모니터링 및 검사 능력 향상에 주력함에 따라 감염증 체외진단 시장은 꾸준히 성장하고 있습니다. 이러한 성장은 병원 및 진단 센터에서의 분자진단, 면역분석법, 그리고 자동화 검사 플랫폼의 활용 확대에 힘입은 것입니다. 북미는 신속한 병원체 확인 및 감염 관리 프로그램을 뒷받침하는 견고한 검사 인프라와 선진적인 의료 시스템을 갖추고 있어, 여전히 매우 중요한 시장으로 남아 있습니다. 정부 기관과 연구 기관은 공중보건 대응 및 질병 감시 체계 강화를 위해 최신 진단 기술의 도입을 지속적으로 추진하고 있습니다.
미국은 체계적인 모니터링 프로그램과 첨단 검사 네트워크를 통해 이러한 발전 과정에서 중심적인 역할을 수행하고 있습니다. 미국 질병통제예방센터(CDC)에 따르면, 항생제 내성 검사 네트워크는 전국 50개 주에서 운영되고 있으며, 여러 지역 검사 기관이 내성 검사 및 유전체 감시를 지원하고 있습니다. 이러한 노력은 첨단 진단 기술의 활용을 강화함으로써, 의료 시스템 전반에 걸친 감염병 탐지 능력 향상과 검사실의 현대화를 지속적으로 뒷받침하고 있습니다.
일본 감염증 체외진단 시장 - 국가별 분석
일본의 감염증 체외진단 시장은 일본의 견고한 공중보건 감시 시스템, 첨단 검사실 인프라, 그리고 감염병 연구 프로그램에 대한 지속적인 지원의 혜택을 받고 있습니다. 정부 기관은 호흡기 감염증, 간염, 결핵 및 항생제 내성 검출을 위한 진단 기술 개발을 적극적으로 추진하고 있습니다. 의약품의료기기종합기구(PMD)는 진단 검사, 예방 조치 및 의료 서비스 대비 태세와 관련된 감염병에 관한 다수의 연구 프로그램을 지원하고 있습니다.
2025년, 일본은 감염병 연구 및 의료에 특화된 국내 연구 기관들을 통합하여 일본 보건안보연구소를 설립했습니다. 산업계에서는 시스멕스가 전 세계 병원 및 연구 기관에 장비, 시약, 검사 시스템을 공급함으로써 체외 진단 사업 영역을 확대하고 있습니다. 한편, 후지리바이오(Fujirebio)는 해외의 자동화 분석 및 바이오마커 개발 프로그램을 활용하여 감염증 및 면역계 진단 역량을 강화하고 있습니다. 이러한 움직임은 진단 정확도 향상, 검사실 효율화, 그리고 미래의 감염병 문제에 대한 대비를 위한 일본의 지속적인 노력을 반영하고 있습니다.
목차
제1장 감염증 체외진단 시장 개요
제2장 주요 요약
제3장 감염증 체외진단 주요 시장 동향
제4장 감염증 체외진단 산업 분석
제5장 감염증 체외진단 시장 : 높아지는 지정학적 긴장의 영향
제6장 감염증 체외진단 시장 구도
제7장 감염증 체외진단 시장 : 제품 유형별
제8장 감염증 체외진단 시장 : 용도별
제9장 감염증 체외진단 시장 : 병원체 유형별
제10장 감염증 체외진단 시장 : 기술별
제11장 감염증 체외진단 시장 : 최종사용자별
제12장 감염증 체외진단 시장 : 지역별
제13장 주요 벤더 분석 : 감염증 체외진단 산업
제14장 AnalystView의 전방위 전망
KSM 26.06.19Infectious Disease In Vitro Diagnostics Market size was valued at US$ 25,203.8 Million in 2025, expanding at a CAGR of 3.2% from 2026 to 2033.
Infectious Disease In Vitro Diagnostics refers to laboratory-based tests and analytical systems used to detect bacteria, viruses, fungi, and other infectious agents from human samples such as blood, saliva, or tissue. These diagnostic solutions help healthcare professionals identify diseases early, guide treatment decisions, monitor infection spread, and support public health management across hospitals, laboratories, and clinics.
The Infectious Disease In Vitro Diagnostics market is expanding with growing attention toward rapid disease detection, laboratory modernization, and outbreak preparedness. Governments and healthcare organizations are strengthening diagnostic infrastructure to improve surveillance of respiratory infections, tuberculosis, hepatitis, HIV, and antimicrobial resistance. The WHO underscored the significance of molecular diagnosis in tuberculosis testing and drug-resistance surveillance programs internationally. Furthermore, the CDC is actively funding antimicrobial resistance laboratory networks and genomic surveillance.
Infectious Disease In Vitro Diagnostics Market- Market Dynamics
Increasing focus on early disease detection and public health preparedness to support diagnostic testing demand
The Increasing focus on early disease detection and public health preparedness is supporting the growth of the Infectious Disease In Vitro Diagnostics market as healthcare systems continue prioritizing rapid identification of bacterial, viral, and fungal infections. Governments are strengthening laboratory surveillance programs and expanding access to molecular testing technologies to reduce delayed diagnosis and improve infection control measures. The World Health Organization (WHO) has emphasized that rapid molecular diagnostic tools are becoming essential for tuberculosis detection and drug-resistance screening, particularly in regions managing high infectious disease burdens. Public health agencies are also encouraging hospitals and laboratories to modernize testing infrastructure for respiratory diseases, antimicrobial resistance, and emerging pathogens.
In relation to the industry, Abbott Laboratories continues to develop its rapid diagnostic testing products using molecular diagnostic technology and point-of-care diagnostics tailored for hospitals, clinics, and other decentralized health centers. In addition, Abbott has developed new capabilities for testing infectious diseases, including respiratory viruses, hepatitis, and sexually transmitted diseases. These developments are helping healthcare providers improve testing turnaround times, support earlier treatment decisions, and strengthen preparedness for future infectious disease outbreaks.
Infectious Disease In Vitro Diagnostics Market- Segmentation Analysis:
The Global Infectious Disease In Vitro Diagnostics Market is segmented on the basis of Product Type, Application, Pathogen Type, Technology, End User, and Region.
Among the Product Type segment, Reagents are expected to hold a significant share due to their continuous and recurring demand in infectious disease diagnostics across hospitals and laboratories. They are widely used in molecular diagnostics, immunoassays, and microbiology testing for diseases such as HIV, hepatitis, and respiratory infections. Unlike instruments, reagents are consumables and require frequent replenishment, ensuring sustained market demand. Growing adoption of automated and high-throughput diagnostic systems is further supporting reagent consumption by improving testing speed and efficiency. Additionally, increasing focus on early disease detection and routine screening is driving their usage across healthcare settings.
Key market players are expanding their reagent portfolios to meet rising demand. Thermo Fisher Scientific continues to strengthen its molecular diagnostic reagent offerings, while QIAGEN provides a wide range of sample preparation reagents and assay kits supporting infectious disease testing workflows.
Infectious Disease In Vitro Diagnostics Market- Geographical Insights
The Infectious Disease In Vitro Diagnostics market is expanding steadily as healthcare systems focus on early disease detection, antimicrobial resistance monitoring, and improved laboratory testing capabilities. Growth is supported by increasing use of molecular diagnostics, immunoassays, and automated testing platforms across hospitals and diagnostic centers. North America remains highly significant due to its strong laboratory infrastructure and advanced healthcare systems that support rapid pathogen identification and infection control programs. Government agencies and research institutions continue to promote modern diagnostic adoption for better public health response and disease surveillance.
The United States plays a central role in this development through structured monitoring programs and advanced laboratory networks. According to the Centers for Disease Control and Prevention (CDC), the Antimicrobial Resistance Laboratory Network operates across all 50 states with multiple regional laboratories supporting resistance testing and genomic surveillance. These initiatives are strengthening the use of advanced diagnostic technologies and supporting continuous improvements in infectious disease detection and laboratory modernization across healthcare systems.
Japan Infectious Disease In Vitro Diagnostics Market- Country Insights
Japan's Infectious Disease In Vitro Diagnostics market is benefiting from the country's strong public health monitoring system, advanced laboratory infrastructure, and continuous support for infectious disease research programs. Government organizations are actively encouraging the development of diagnostic technologies for respiratory infections, hepatitis, tuberculosis, and antimicrobial resistance detection. Japan Agency for Medical Research and Development sponsors many research programs concerning infectious diseases in relation to diagnostic tests, preventive measures, and readiness of health services.
In 2025, Japan set up the Japan Institute for Health Security through the merger of Japan's institutes dedicated to the research of infectious diseases and medical care. In the industrial sector, Sysmex expands its business in in vitro diagnostics by providing machines, reagents, and laboratory systems for hospitals and research institutions around the world. On the other hand, Fujirebio is enhancing its ability to diagnose infectious diseases and immune systems using automated assays and biomarker development programs abroad. These developments reflect Japan's sustained attention toward improving diagnostic accuracy, laboratory efficiency, and preparedness for future infectious disease challenges.
Infectious Disease In Vitro Diagnostics Market- Competitive Landscape:
The Infectious Disease In Vitro Diagnostics market is shaped by the presence of multinational healthcare technology firms and specialized diagnostic developers focused on expanding rapid disease detection and laboratory efficiency. Companies such as Abbott Laboratories, QIAGEN, bioMerieux, BD, and Thermo Fisher Scientific have been expanding their testing capabilities using molecular technology, automation systems, and extensive reagent offerings. Other companies are upgrading their digital laboratory capabilities and decentralized testing systems to help hospitals, clinics, and government health labs cope with the demands of infectious disease testing.
Recent Developments:
In May 2026, Roche announced a definitive agreement to acquire PathAI to strengthen artificial intelligence-enabled digital pathology and infectious disease diagnostic capabilities. The transaction is intended to improve laboratory workflow automation and support precision diagnostic development across global healthcare systems.
In April 2026, Cepheid and Oxford Nanopore Technologies expanded their collaboration to develop rapid genomic workflows for bacterial and fungal pathogen identification. The partnership focuses on improving infectious disease research and antimicrobial resistance analysis through advanced sequencing technologies.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- QIAGEN
- bioMerieux
- BD
- Thermo Fisher Scientific
- Siemens Healthineers
- Bio-Rad Laboratories
- Danaher Corporation
- Hologic
- QuidelOrtho
- OraSure Technologies
- DiaSorin
- Sysmex
- Agilent Technologies
- Illumina
- Beckman Coulter
- Meridian Bioscience
- Trinity Biotech
- Eiken Chemical
- Luminex Corporation
- Others
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Reagents
- Assay Kits
- Instruments
- Software
- Others
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Hospital-Acquired Infections
- MRSA
- Streptococcus
- Clostridium difficile
- VRE
- CRE
- Respiratory Infections
- Respiratory Virus
- COVID-19
- TB & Drug-Resistant TB
- Sexually Transmitted Infections
- Chlamydia
- Gonorrhea
- HPV
- HIV
- Hepatitis Testing
- Hepatitis B
- Hepatitis C
- Gastrointestinal & Fungal Infections
- Gastro-intestinal Panel Testing
- Candida
- Other Infectious Diseases
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY PATHOGEN TYPE - MARKET ANALYSIS, 2020 - 2033
- Bacterial Infections
- Viral Infections
- Parasitic Infections
- Fungal Infections
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Molecular Diagnostics
- Immunodiagnostics,
- Microbiology
- Others
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Home Care Settings
- Others
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. Infectious Disease In Vitro Diagnostics Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Infectious Disease In Vitro Diagnostics Market Snippet by Product Type
- 2.1.2. Infectious Disease In Vitro Diagnostics Market Snippet by Application
- 2.1.3. Infectious Disease In Vitro Diagnostics Market Snippet by Pathogen Type
- 2.1.4. Infectious Disease In Vitro Diagnostics Market Snippet by Technology
- 2.1.5. Infectious Disease In Vitro Diagnostics Market Snippet by End User
- 2.1.6. Infectious Disease In Vitro Diagnostics Market Snippet by Country
- 2.1.7. Infectious Disease In Vitro Diagnostics Market Snippet by Region
- 2.2. Competitive Insights
3. Infectious Disease In Vitro Diagnostics Key Market Trends
- 3.1. Infectious Disease In Vitro Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Infectious Disease In Vitro Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Infectious Disease In Vitro Diagnostics Market Opportunities
- 3.4. Infectious Disease In Vitro Diagnostics Market Future Trends
4. Infectious Disease In Vitro Diagnostics Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Infectious Disease In Vitro Diagnostics Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Infectious Disease In Vitro Diagnostics Market Landscape
- 6.1. Infectious Disease In Vitro Diagnostics Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Infectious Disease In Vitro Diagnostics Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
- 7.1.2. Reagents
- 7.1.3. Assay Kits
- 7.1.4. Instruments
- 7.1.5. Software
- 7.1.6. Others
8. Infectious Disease In Vitro Diagnostics Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. Hospital-Acquired Infections
- 8.1.2.1. MRSA
- 8.1.2.2. Streptococcus
- 8.1.2.3. Clostridium difficile
- 8.1.2.4. VRE
- 8.1.2.5. CRE
- 8.1.3. Respiratory Infections
- 8.1.3.1. Respiratory Virus
- 8.1.3.2. COVID-19
- 8.1.3.3. TB & Drug-Resistant TB
- 8.1.4. Sexually Transmitted Infections
- 8.1.4.1. Chlamydia
- 8.1.4.2. Gonorrhea
- 8.1.4.3. HPV
- 8.1.4.4. HIV
- 8.1.5. Hepatitis Testing
- 8.1.5.1. Hepatitis B
- 8.1.5.2. Hepatitis C
- 8.1.6. Gastrointestinal & Fungal Infections
- 8.1.6.1. Gastro-intestinal Panel Testing
- 8.1.6.2. Candida
- 8.1.7. Other Infectious Diseases
9. Infectious Disease In Vitro Diagnostics Market - By Pathogen Type
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Pathogen Type, 2025 & 2033 (%)
- 9.1.2. Bacterial Infections
- 9.1.3. Viral Infections
- 9.1.4. Parasitic Infections
- 9.1.5. Fungal Infections
10. Infectious Disease In Vitro Diagnostics Market - By Technology
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
- 10.1.2. Molecular Diagnostics
- 10.1.3. Immunodiagnostics,
- 10.1.4. Microbiology
- 10.1.5. Others
11. Infectious Disease In Vitro Diagnostics Market - By End User
- 11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 11.1.2. Hospitals
- 11.1.3. Diagnostic Laboratories
- 11.1.4. Research Institutes
- 11.1.5. Home Care Settings
- 11.1.6. Others
12. Infectious Disease In Vitro Diagnostics Market- By Geography
- 12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 12.2. North America
- 12.2.1. Overview
- 12.2.2. Infectious Disease In Vitro Diagnostics Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
- 12.2.9.1. Overview
- 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.2.9.5. U.S. Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.2.9.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
- 12.2.10.1. Overview
- 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.2.10.5. Canada Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.2.10.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3. Europe
- 12.3.1. Overview
- 12.3.2. Infectious Disease In Vitro Diagnostics Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
- 12.3.9.1. Overview
- 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.9.5. Germany Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.3.9.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.10. UK
- 12.3.10.1. Overview
- 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.10.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.10.5. UK Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.3.10.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.11. France
- 12.3.11.1. Overview
- 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.11.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.11.5. France Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.3.11.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
- 12.3.12.1. Overview
- 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.12.5. Italy Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.3.12.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
- 12.3.13.1. Overview
- 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.13.5. Spain Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.3.13.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
- 12.3.14.1. Overview
- 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.14.5. The Netherlands Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.3.14.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
- 12.3.15.1. Overview
- 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.15.5. Sweden Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.3.15.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
- 12.3.16.1. Overview
- 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.16.5. Russia Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.3.16.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
- 12.3.17.1. Overview
- 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.17.5. Poland Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.3.17.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.18. Denmark
- 12.3.18.1. Overview
- 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.18.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.3.18.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.18.5. Denmark Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.3.18.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.19. Rest of Europe
- 12.3.19.1. Overview
- 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.19.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.3.19.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.19.5. Rest of the Europe Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.3.19.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Infectious Disease In Vitro Diagnostics Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.9. China
- 12.4.9.1. Overview
- 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.9.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.9.5. China Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.4.9.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.10. India
- 12.4.10.1. Overview
- 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.10.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.10.5. India Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.4.10.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
- 12.4.11.1. Overview
- 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.11.5. Japan Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.4.11.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
- 12.4.12.1. Overview
- 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.12.5. South Korea Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.4.12.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
- 12.4.13.1. Overview
- 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.13.5. Australia Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.4.13.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
- 12.4.14.1. Overview
- 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.14.5. Indonesia Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.4.14.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
- 12.4.15.1. Overview
- 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.15.5. Thailand Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.4.15.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
- 12.4.16.1. Overview
- 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.16.5. Philippines Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.4.16.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.17. Taiwan
- 12.4.17.1. Overview
- 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.17.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.4.17.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.17.5. Taiwan Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.4.17.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.18. Vietnam
- 12.4.18.1. Overview
- 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.18.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.4.18.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.18.5. Vietnam Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.4.18.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.19. Rest of APAC
- 12.4.19.1. Overview
- 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.19.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.4.19.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.19.5. Rest of APAC Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.4.19.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Infectious Disease In Vitro Diagnostics Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
- 12.5.9.1. Overview
- 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.9.5. Brazil Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.5.9.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
- 12.5.10.1. Overview
- 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.10.5. Mexico Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.5.10.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
- 12.5.11.1. Overview
- 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.11.5. Argentina Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.5.11.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
- 12.5.12.1. Overview
- 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.12.5. Colombia Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.5.12.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
- 12.5.13.1. Overview
- 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.13.5. Rest of LATAM Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Infectious Disease In Vitro Diagnostics Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
- 12.6.9.1. Overview
- 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.9.5. Saudi Arabia Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
- 12.6.10.1. Overview
- 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.10.5. United Arab Emirates Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
- 12.6.11.1. Overview
- 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.11.5. Israel Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.6.11.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
- 12.6.12.1. Overview
- 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.12.5. Turkey Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.6.12.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
- 12.6.13.1. Overview
- 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.13.5. Algeria Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.6.13.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
- 12.6.14.1. Overview
- 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.14.5. Egypt Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.6.14.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.15. Iran
- 12.6.15.1. Overview
- 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.15.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.6.15.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.15.5. Iran Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.6.15.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.16. Qatar
- 12.6.16.1. Overview
- 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.16.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.6.16.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.16.5. Qatar Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.6.16.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.17. Rest of MEA
- 12.6.17.1. Overview
- 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.17.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 12.6.17.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.17.5. Rest of MEA Market Size and Forecast, By Pathogen Type , 2020 - 2033 (US$ Million)
- 12.6.17.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Infectious Disease In Vitro Diagnostics Industry
- 13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
- 13.2. Company Profiles
- 13.2.1. Abbott Laboratories
- 13.2.2. QIAGEN
- 13.2.3. bioMerieux
- 13.2.4. BD
- 13.2.5. Thermo Fisher Scientific
- 13.2.6. Siemens Healthineers
- 13.2.7. Bio-Rad Laboratories
- 13.2.8. Danaher Corporation
- 13.2.9. Hologic
- 13.2.10. QuidelOrtho
- 13.2.11. OraSure Technologies
- 13.2.12. DiaSorin
- 13.2.13. Sysmex
- 13.2.14. Agilent Technologies
- 13.2.15. Illumina
- 13.2.16. Beckman Coulter
- 13.2.17. Meridian Bioscience
- 13.2.18. Trinity Biotech
- 13.2.19. Eiken Chemical
- 13.2.20. Luminex Corporation
- 13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
- 15.1. Research Methodology
- 15.2. References
- 15.3. Abbreviations
- 15.4. Disclaimer
- 15.5. Contact Us
